Pylarify
Active Awarded Last action
- Contract number
- 36C25726N0177
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,940,665
Award facts
- Contract value 100% obligated
- $1,940,665.20 Current and potential, with all options
- Completion date 79% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $126,305 | |
| Original award | $1,814,360 |
About this award
Veterans Integrated Service Network 17 issued a BPA call to Progenics Pharmaceuticals Inc. (a division of Lantheus Medical Imaging, Inc.) on January 6, 2026, with a ceiling value of $1,940,665.20 for PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent for positron emission tomography scans. The call is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA schedule vehicle. Place of performance is North Billerica, Billerica, Massachusetts. The ultimate completion date is January 4, 2027. Pricing is firm fixed price. This represents an option increase for an existing BPA call.
Quick answers
Who was awarded contract 36C25726N0177?
36C25726N0177 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on January 6, 2026.
How much is contract 36C25726N0177 worth?
The government has obligated $1,940,665 on 36C25726N0177.
Is contract 36C25726N0177 an order under another contract?
Yes. 36C25726N0177 is a BPA call under 36F79725D0093-36C25726A0014, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25726N0177 competed?
The extent of competition for 36C25726N0177 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award